LINK vs NBIX · rev $11.7M vs P/E 45, rev $2.36B
Interlink Electronics Inc (LINK) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Interlink Electronics Inc (LINK) is a electronic components company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported LINK revenue for 2024-12-31 was $11.7M. Net income was -$2.0M. Revenue was down 16.2% from 2023-12-31 to 2024-12-31. LINK currently screens at market cap $67.3M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
LINK currently screens at market cap $67.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the LINK and NBIX stock pages for the full models.
Not investment advice.